全文获取类型
收费全文 | 2592篇 |
免费 | 173篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 96篇 |
妇产科学 | 41篇 |
基础医学 | 297篇 |
口腔科学 | 22篇 |
临床医学 | 234篇 |
内科学 | 456篇 |
皮肤病学 | 43篇 |
神经病学 | 244篇 |
特种医学 | 209篇 |
外科学 | 282篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 284篇 |
眼科学 | 13篇 |
药学 | 299篇 |
肿瘤学 | 252篇 |
出版年
2023年 | 12篇 |
2022年 | 17篇 |
2021年 | 46篇 |
2020年 | 38篇 |
2019年 | 36篇 |
2018年 | 43篇 |
2017年 | 45篇 |
2016年 | 39篇 |
2015年 | 50篇 |
2014年 | 59篇 |
2013年 | 102篇 |
2012年 | 119篇 |
2011年 | 113篇 |
2010年 | 99篇 |
2009年 | 91篇 |
2008年 | 94篇 |
2007年 | 137篇 |
2006年 | 88篇 |
2005年 | 104篇 |
2004年 | 83篇 |
2003年 | 89篇 |
2002年 | 80篇 |
2001年 | 80篇 |
2000年 | 78篇 |
1999年 | 58篇 |
1998年 | 67篇 |
1997年 | 73篇 |
1996年 | 73篇 |
1995年 | 62篇 |
1994年 | 57篇 |
1993年 | 35篇 |
1992年 | 49篇 |
1991年 | 62篇 |
1990年 | 52篇 |
1989年 | 64篇 |
1988年 | 58篇 |
1987年 | 46篇 |
1986年 | 52篇 |
1985年 | 33篇 |
1984年 | 17篇 |
1983年 | 30篇 |
1982年 | 22篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 15篇 |
1978年 | 12篇 |
1977年 | 16篇 |
1976年 | 12篇 |
1970年 | 9篇 |
1969年 | 12篇 |
排序方式: 共有2805条查询结果,搜索用时 15 毫秒
81.
82.
83.
Hermine A van Duyvenvoorde Julian C Lui Sarina G Kant Wilma Oostdijk Antoinet CJ Gijsbers Mari?tte JV Hoffer Marcel Karperien Marie JE Walenkamp Cees Noordam Paul G Voorhoeve Verónica Mericq Alberto M Pereira Hedi L Claahsen-van de Grinten Sandy A van Gool Martijn H Breuning Monique Losekoot Jeffrey Baron Claudia AL Ruivenkamp Jan M Wit 《European journal of human genetics : EJHG》2014,22(5):602-609
Height is a highly heritable and classic polygenic trait. Recent genome-wide association studies (GWAS) have revealed that at least 180 genetic variants influence adult height. However, these variants explain only about 10% of the phenotypic variation in height. Genetic analysis of short individuals can lead to the discovery of novel rare gene defects with a large effect on growth. In an effort to identify novel genes associated with short stature, genome-wide analysis for copy number variants (CNVs), using single-nucleotide polymorphism arrays, in 162 patients (149 families) with short stature was performed. Segregation analysis was performed if possible, and genes in CNVs were compared with information from GWAS, gene expression in rodents'' growth plates and published information. CNVs were detected in 40 families. In six families, a known cause of short stature was found (SHOX deletion or duplication, IGF1R deletion), in two combined with a de novo potentially pathogenic CNV. Thirty-three families had one or more potentially pathogenic CNVs (n=40). In 24 of these families, segregation analysis could be performed, identifying three de novo CNVs and nine CNVs segregating with short stature. Four were located near loci associated with height in GWAS (ADAMTS17, TULP4, PRKG2/BMP3 and PAPPA). Besides six CNVs known to be causative for short stature, 40 CNVs with possible pathogenicity were identified. Segregation studies and bioinformatics analysis suggested various potential candidate genes. 相似文献
84.
Arjan PM de Brouwer Sander B Nabuurs Ingrid EC Verhaart Astrid R Oudakker Roel Hordijk Helger G Yntema Jannet M Hordijk-Hos Krysta Voesenek Bert BA de Vries Ton van Essen Wei Chen Hao Hu Jamel Chelly Johan T den Dunnen Vera M Kalscheuer Annemieke M Aartsma-Rus Ben CJ Hamel Hans van Bokhoven Tjitske Kleefstra 《European journal of human genetics : EJHG》2014,22(4):480-485
We have identified a deletion of 3 base pairs in the dystrophin gene (DMD), c.9711_9713del, in a family with nonspecific X-linked intellectual disability (ID) by sequencing of the exons of 86 known X-linked ID genes. This in-frame deletion results in the deletion of a single-amino-acid residue, Leu3238, in the brain-specific isoform Dp71 of dystrophin. Linkage analysis supported causality as the mutation was present in the 7.6 cM linkage interval on Xp22.11–Xp21.1 with a maximum positive LOD score of 2.41 (MRX85 locus). Molecular modeling predicts that the p.(Leu3238del) deletion results in the destabilization of the C-terminal domain of dystrophin and hence reduces the ability to interact with β-dystroglycan. Correspondingly, Dp71 protein levels in lymphoblastoid cells from the index patient are 6.7-fold lower than those in control cell lines (P=0.08). Subsequent determination of the creatine kinase levels in blood of the index patient showed a mild but significant elevation in serum creatine kinase, which is in line with impaired dystrophin function. In conclusion, we have identified the first DMD mutation in Dp71 that results in ID without muscular dystrophy. 相似文献
85.
Vermeulen I Weets I Costa O Asanghanwa M Verhaeghen K Decochez K Ruige J Casteels K Wenzlau J Hutton JC Pipeleers DG Gorus FK;Belgian Diabetes Registry 《Diabetologia》2012,55(2):413-420
Aims/hypothesis
The appearance of autoantibodies (Abs) before diabetes onset has mainly been studied in young children. However, most patients develop type 1 diabetes after the age of 15?years. In first-degree relatives aged under 40?years, we investigated the frequency of seroconversion to (persistent) Ab positivity, progression to diabetes and baseline characteristics of seroconverters according to age.Methods
Abs against insulin (IAA), glutamate decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A) and zinc transporter 8 (ZnT8A) were measured during follow-up of 7,170 first-degree relatives.Results
We identified 379 (5.3%) relatives with positivity for IAA, GADA, IA-2A and/or ZnT8A (Ab+) at first sampling and 224 (3.1%) at a later time point. Most seroconversions occurred after the age of 10?years (63%). During follow-up, Abs persisted more often in relatives initially Ab+ (76%) than in seroconverters (53%; p?0.001). In both groups diabetes developed at a similar pace and almost exclusively with Ab persistence (136 of 139 prediabetic individuals). For both groups, progression was more rapid if Abs appeared before the age of 10?years. Baseline characteristics at seroconversion did not vary significantly according to age.Conclusions/interpretation
Seroconversion to (persistent) Ab+ occurs regardless of age. Although the progression rate to diabetes is higher under age 10?years, later seroconverters (up to age 40?years) have similar characteristics when compared with age-matched initially Ab+ relatives and generate an important minority of prediabetic relatives, warranting their identification and, eventually, enrolment in prevention trials. 相似文献86.
van Stijn MF Vermeulen MA Siroen MP Wong LN van den Tol MP Ligthart-Melis GC Houdijk AP van Leeuwen PA 《Metabolism: clinical and experimental》2012,61(7):1036-1040
Taurine is involved in numerous biological processes. However, taurine plasma level decreases in response to pathological conditions, suggesting an increased need. Knowledge on human taurine metabolism is scarce and only described by arterial-venous differences across a single organ. Here we present taurine organ fluxes using arterial-venous concentration differences combined with blood flow measurements across the 3 major organ systems involved in human taurine metabolism in patients undergoing hepatic surgery. In these patients, we collected blood from an arterial line, portal vein, hepatic vein, and renal vein, and determined blood flow of the hepatic artery, portal vein, and renal vein using Doppler ultrasound. Plasma taurine was determined by high-performance liquid chromatography, and net organ fluxes and fractional extraction rates were calculated. Seventeen patients were studied. No differences were found between taurine concentrations in arterial, portal venous, hepatic venous, and renal venous plasma. The only significant finding was a release of taurine by the portally drained viscera (P = .04). Our data show a net release of taurine by the gut. This probably is explained by the enterohepatic cycle of taurine. Future studies on human taurine metabolism are required to determine whether taurine is an essential aminosulfonic acid during pathological conditions and whether it should therefore be supplemented. 相似文献
87.
88.
89.
90.
Gielens MP Mulder IM van der Harst E Gosselink MP Kraal KJ Teng HT Lange JF Vermeulen J 《Techniques in coloproctology》2012,16(5):363-368